November, 2025
November 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
OCCUPI Trial Analysis Highlights Benefits of OCT Guidance in ACS Patients
Nov 4, 2025, 09:10

OCCUPI Trial Analysis Highlights Benefits of OCT Guidance in ACS Patients

Davide Capodanno, Professor of Cardiology at University of Catania, editor-in-Chief of EuroIntervention, posted on X.

“In this post hoc analysis of patients with acute coronary syndromes in the OCCUPI trial, the primary outcome—1-year composite of cardiac death, myocardial infarction, stent thrombosis, or ischemia-driven target vessel revascularisation—occurred in 4.9% of the OCT-guided group versus 9.5% in the angiography-guided group (HR 0.50, 95% CI 0.29–0.87; p=0.011; p=0.273 for interaction). Such benefit was particularly observed in patients who achieved stent optimisation by OCT.”

Read ARTICLE here EDITORIAL here.

 Davide Capodanno

Stay updated with Hemostasis Today.